WilmerHale Counsels Karyopharm Therapeutics in Public Offering of Shares

Download IconDownload Print IconPrint

WilmerHale Counsels Karyopharm Therapeutics in Public Offering of Shares

Firm News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Lawyers with deep and broad experience counseling clients in every industry on the design, implementation, and interpretation of executive compensation arrangements and on general compensation and benefits issues.

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, has announced the closing of its previously announced registered underwritten public offering and the exercise in full of the underwriters' option to purchase additional shares. 

The WilmerHale team counseling Karyopharm was led by Jason Kropp and Steven Singer, and included Bruce Manheim, Kimberly Wethly, Jeffries Oliver-Li, Meghan Walsh, Brett Bromann and Michael Lopes.

Read Karyopharm's press release for more information.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel